The Icahn School of Medicine at Mount Sinai has received a $4 million, five-year P30 grant from NIH and the National Institute of Arthritis and Musculoskeletal and Skin Diseases to establish a Skin Biology and Diseases Resource-based Center.
As the Galleri test is advancing toward becoming the first multi-cancer detection test to secure FDA approval, cancer care providers are coming up with strategies for using these tests responsibly.
